Catalyst Pharmaceuticals, Inc.
US ˙ NASDAQCM ˙ US14888U1016 ˙ Medical Devices
DIESES SYMBOL IST NICHT MEHR AKTIV

SecurityCPRX / Catalyst Pharmaceuticals, Inc.
InstitutionState Board Of Administration Of Florida Retirement System
Latest Disclosed Ownership58,215 shares
Latest Disclosed Value $ 1,829,697
State Board Of Administration Of Florida Retirement System reports 30.74% increase in ownership of CPRX / Catalyst Pharmaceuticals, Inc.

On August 10, 2026 - State Board Of Administration Of Florida Retirement System filed a 13F-HR form disclosing ownership of 58,215 shares of Catalyst Pharmaceuticals, Inc. (US:CPRX) valued at $1,829,697 USD as of June 30, 2026. The entity filed a previous 13F-HR on May 8, 2026 disclosing 44,529 shares of Catalyst Pharmaceuticals, Inc.. This represents a change in shares of 30.74% during the quarter. The current value of the position is $1,833,190 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-08-10 2026-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 58,215 13,686 30.74 1,830 65.97 0.0030
2026-05-08 2026-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 44,529 0 0.00 1,103 6.06 0.0021
2026-02-12 2025-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 44,529 0 0.00 1,039 18.47 0.0018
2025-11-14 2025-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 44,529 0 0.00 877 -9.21 0.0015
2025-08-13 2025-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 44,529 0 0.00 966 -10.47 0.0017
2025-05-12 2025-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 44,529 -1,522 -3.31 1,080 12.28 0.0021
2025-02-10 2024-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 46,051 0 0.00 961 5.03 0.0018
2024-11-08 2024-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 46,051 17,391 60.68 915 106.55 0.0017
2024-08-08 2024-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 28,660 7,800 37.39 444 28.41 0.0009
2024-05-08 2024-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 20,860 -7,800 -27.22 346 -28.27 0.0008
2024-02-09 2023-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 28,660 0 0.00 482 43.58 0.0010
2023-11-08 2023-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 28,660 1,290 4.71 335 -8.72 0.0008
2023-08-11 2023-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 27,370 6,510 31.21 368 6.38 0.0008
2023-06-14 2023-03-31 13F/A-1 CATALYST PHARMACEUTICALS COM 14888U101 20,860 0 0.00 346 -10.85 0.0008
2023-05-11 2023-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 20,860 0 0 0.0008
2023-06-14 2022-12-31 13F/A-1 CATALYST PHARMACEUTICALS COM 14888U101 20,860 -129,197 -86.10 388 -79.90 0.0010
2023-02-07 2022-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 20,860 -129,197 0 0.0010
2022-11-08 2022-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 150,057 -165,449 -52.44 1,925 -12.97 0.0049
2022-08-05 2022-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 315,506 19,607 6.63 2,212 -9.82 0.0054
2022-05-06 2022-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 295,899 -43,983 -12.94 2,453 6.61 0.0048
2022-02-08 2021-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 339,882 -55,464 -14.03 2,301 9.83 0.0041
2021-11-08 2021-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 395,346 -1,948 -0.49 2,095 -8.27 0.0041
2021-08-10 2021-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 397,294 -177,388 -30.87 2,284 -13.78 0.0043
2021-05-10 2021-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 574,682 554,902 2,805.37 2,649 3,913.64 0.0053
2021-02-08 2020-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 19,780 0 0.00 66 11.86 0.0001
2020-11-09 2020-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 19,780 0 0.00 59 -35.16 0.0001
2020-08-07 2020-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 19,780 0 0.00 91 19.74 0.0002
2020-05-05 2020-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 19,780 -220 -1.10 76 1.33 0.0002
2020-02-03 2019-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 20,000 0 0.00 75 -29.25 0.0002
2019-11-07 2019-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 20,000 0 0.00 106 37.66 0.0003
2019-08-05 2019-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 20,000 0 0.00 77 -24.51 0.0002
2019-05-03 2019-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 20,000 0 0.00 102 168.42 0.0003
2019-02-01 2018-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 20,000 0 0.00 38 -50.00 0.0001
2018-10-31 2018-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 20,000 0 0.00 76 22.58 0.0002
2018-08-06 2018-06-30 13F CATALYST PHARMACEUTICALS COM 14888U101 20,000 0 0.00 62 29.17 0.0002
2018-05-04 2018-03-31 13F CATALYST PHARMACEUTICALS COM 14888U101 20,000 0 0.00 48 -38.46 0.0001
2018-02-01 2017-12-31 13F CATALYST PHARMACEUTICALS COM 14888U101 20,000 0 0.00 78 56.00 0.0002
2017-10-31 2017-09-30 13F CATALYST PHARMACEUTICALS COM 14888U101 20,000 20,000 50 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.